Literature DB >> 11940351

Expression of telomerase activity, telomerase RNA component and telomerase catalytic subunit gene in lung cancer.

Weiwei Chen1, Xiaoxiong Xiong, Hongyuan Zhou, Qinghua Zhou.   

Abstract

OBJECTIVE: To investigate whether telomerase activity, human telomerase RNA (HTR) and human telomerase reverse transcriptase (HTERT) expression were associated with tumor development in lung cancer and whether telomerase is regulated at gene level or transcriptional level.
METHODS: Expression of HTR and HTERT was detected by reverse transcription-polymerase chain reaction (RT-PCR) in 68 human lung cancer and in 68 adjacent-neoplatic lung tissues. And telomerase activity was examined by a quantitative telomeric repeat amplification protocol (TRAP).
RESULTS: In 68 lung cancer tissues, telomerase activity, HTR and HTERT were expressed in 79%, 98.5% and 91.2% respectively, whereas all adjacent non-neoplastic lung tissues were telomerase negative. Most normal lung tissues expressed HTR (91.2%) and HTERT was detected in only 7 of 68 non-neoplastic tissues.
CONCLUSIONS: The relatively high frequency of telomerase activity in lung cancer whereas the detection of no telomerase activity in normal lung tissues suggested that telomerase may play an important role in tumorigenesis of lung cancer. Compared to HTR, HTERT expression was better associated with telomerase activity with a concordance of 88.9%. Telomerase activity may be regulated at transcription level or translation level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940351

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  2 in total

Review 1.  Expression of telomerase & its significance in the diagnosis of pancreatic cancer.

Authors:  Anutebeh Verdo Zisuh; Tian-Quan Han; Shen-Dao Zhan
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

2.  Telomerase Activity is Downregulated Early During Human Brain Development.

Authors:  Abbas Ishaq; Peter S Hanson; Christopher M Morris; Gabriele Saretzki
Journal:  Genes (Basel)       Date:  2016-06-16       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.